🔎 Trials Near Me

Home › Waldenstrom Macroglobulinemia › Colorado

Pag-aaral pangklinika para sa Waldenstrom Macroglobulinemia sa Colorado

8 pag-aaral para sa Waldenstrom Macroglobulinemia ang naghahanap ng mga kalahok sa mga site sa Colorado.

Mga Lungsod sa Colorado

Opisyal na teksto ng pag-aaral (English)

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  • Uchealth North, Fort Collins
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05006716

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

  • Colorado Blood Cancer Institute ( Site 2726), Denver
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04728893

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  • University of Colorado Denver - School of Medicine - Anschutz Medical Campus, Aurora
  • Colorado Blood Cancer Institute, Denver
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07101328

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

  • Colorado Blood Cancer Institute (CBCI), Denver
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06561347

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

  • Colorado Blood Cancer Institute, Denver
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05131022

SynKIR-310 for Relapsed/Refractory B-NHL

  • Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute, Denver
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 14, 2026 · NCT06544265

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

  • Sarah Cannon Research Institute at Colorado Blood Cancer Institute, Denver
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT04830137

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

  • Colorado Blood Cancer Institute, Denver
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2025 · NCT05780034

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.